Eli Lilly (LLY) Non-Current Assets (2016 - 2025)
Historic Non-Current Assets for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $56.8 billion.
- Eli Lilly's Non-Current Assets rose 2364.76% to $56.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $208.9 billion, marking a year-over-year increase of 2246.02%. This contributed to the annual value of $56.8 billion for FY2025, which is 2364.76% up from last year.
- As of Q4 2025, Eli Lilly's Non-Current Assets stood at $56.8 billion, which was up 2364.76% from $52.9 billion recorded in Q3 2025.
- Over the past 5 years, Eli Lilly's Non-Current Assets peaked at $56.8 billion during Q4 2025, and registered a low of $29.8 billion during Q3 2022.
- Over the past 5 years, Eli Lilly's median Non-Current Assets value was $34.2 billion (recorded in 2023), while the average stood at $38.1 billion.
- Per our database at Business Quant, Eli Lilly's Non-Current Assets plummeted by 185.2% in 2022 and then soared by 2659.32% in 2024.
- Eli Lilly's Non-Current Assets (Quarter) stood at $30.4 billion in 2021, then rose by 3.63% to $31.5 billion in 2022, then grew by 21.69% to $38.3 billion in 2023, then increased by 20.1% to $46.0 billion in 2024, then increased by 23.65% to $56.8 billion in 2025.
- Its Non-Current Assets stands at $56.8 billion for Q4 2025, versus $52.9 billion for Q3 2025 and $51.1 billion for Q2 2025.